Question 1

What is the ESG rating for ADCT?

Accepted Answer

ADC Therapeutics SA has the following ESG ratings: ESG Enterprise Score: 35.3 (E:N/A S:N/A G:N/A).

Question 2

What are the main strengths of investing in ADCT?

Accepted Answer

The main strengths of investing in ADC Therapeutics SA include: Strong commitment to ESG principles, Positive impact on cancer treatment, Experienced management team..

Question 3

What are the potential drawbacks of investing in ADCT?

Accepted Answer

Potential drawbacks of investing in ADC Therapeutics SA include: Dependence on a single product, High levels of debt..

Question 4

What are the key financial metrics for ADCT?

Accepted Answer

Key financial metrics for ADC Therapeutics SA include: Market Cap: $23.63 billion, Current Price: $505.79.

ADC Therapeutics SA

Detailed View

ADCT

ESG Ratings